Medreonet, A European Project On Bluetongue And African Horse Sickness
Main Category: VeterinaryAlso Included In: Infectious Diseases / Bacteria / Viruses; Water - Air Quality / Agriculture
Article Date: 24 Mar 2007 - 0:00 PDT
| Patient / Public: | ![]() |
1 (1 votes) |
| Healthcare Prof: | ![]() |
5 (2 votes) |
Three animal diseases transmitted by Culicoides (small biting midges) are under study by Medreonet. They are:
- bluetongue, which mainly affects sheep but has also been seen in cattle since last summer; it is currently affecting Europe, and the whole of the intertropical zone, from the United States to Australia and South Africa;
- African horse sickness, which affects horses, currently in Subsaharan Africa; it is now threatening southern Europe;
- epizootic haemorrhagic disease (EHD), which affects deer but can infect cattle, currently in the United States and South Africa; it has just reached Israel and the Maghreb.
As Guillaume Gerbier, a researcher with the CIRAD Epidemiology and Ecology of Animal Diseases Internal Research Unit and coordinator of the project, points out: "One of these diseases has already hit Europe and the other two are a risk for Europe. We are therefore keen to pool the experiences of research teams in the 17 participating countries and harmonize the control methods used against these diseases". To this end, regular meetings are due to be organized, the first of which has just been held in Montpellier.
Surveillance protocols
Several research topics are already under study by the 21 partner organizations in the project (in Europe, around the Mediterranean and in South Africa, the country that discovered bluetongue at the start of the 1900s).
Surveillance of disease circulation (serological and virological analyses) is a priority. This is followed by surveillance of the vector insects (trapping and identification, since not all the vectors are known, although researchers say there are "suspect" European species). The next step will be to analyse the genome of the virus, sequence it and build groups of virus families so as to determine their origin. In fact, there are 24 bluetongue virus serotypes, and the disease serves as a model in studies of emerging diseases. "Infection by one serotype does not protect against the other 23," says Guillaume Gerbier, "and to date, we have only recorded eight serotypes around the Mediterranean since the bluetongue epidemic of 1999".
CIRAD and its French partners are currently working closely to monitor the emergence of new serotypes around the Mediterranean and draw up bluetongue surveillance protocols. Researchers are concerned that the disease may recur in the spring. The aim in the medium term is also to set up a joint observatory.
About the CIRAD
The Agricultural Research Centre for International Development, CIRAD, is a French agricultural research centre working for development in developing countries and the French overseas regions. Most of its research is conducted in partnership. It employs 1 850 people, including 950 senior staff members, and has an annual operating budget of 170 million euros.
CIRAD
TA 483/05 avenue Agropolis
Montpellier Cedex 5
http://www.cirad.fr
Visit our veterinary section for the latest news on this subject.
MLA
16 Feb. 2012. <http://www.medicalnewstoday.com/releases/66016.php>
APA
http://www.medicalnewstoday.com/releases/66016.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.




